MSD Committed to bringing out the best in medicine
Contact Us
Healthcare Professionals HomeProductsunivadisMSD InformaticsMerck Manuals
 

Products Available in the UK
World Leading Portfolio

Products in our portfolio include treatments for asthma, cardiovascular problems, emesis, glaucoma, gout, hair loss, HIV/AIDS, benign prostatic hyperplasia, infection, migraine, osteoarthritis, osteoporosis and arthritis.

Brand name Generic name Therapy area
ARCOXIA® etoricoxib Arthritis
AGGRASTAT® tirofiban Cardiovascular
COSOPT® dorzolamide plus timolol Ophthalmology
COZAAR® losartan Blood Pressure
COZAAR-Comp® losartan plus hydrochlorothiazide Blood Pressure
CRIXIVAN® indinavir HIV
EZETROL® ezetimibe Hypercholesterolaemia
FOSAMAX® alendronate Osteoporosis
FOSAVANCE® alendronate Osteoporosis
FOSAMAX ONCE-WEEKLY® alendronate Osteoporosis
JANUVIA® sitagliptan Type 2 Diabetes
INEGY® ezetimibe plus simvastatin Hypercholesterolaemia
INEGY® ezetimibe plus simvastatin Hypercholesterolaemia
MAXALT® rizatriptan Migraine
PRIMAXIN® IM Injection imipenum plus cilastatin Infection
PRIMAXIN® IV Injection imipenum plus cilastatin Infection
PROPECIA® finasteride Hair loss
PROSCAR® finasteride Urology
SINGULAIR® montelukast Asthma
TIMOPTOL® timolol Ophthalmology
TRUSOPT® dorzolamide Ophthalmology

 
RESEARCH

It costs about £550 million over 12 years to bring one medicine from discovery in a laboratory to the patient.
>>Read more about MSD's research in the UK
 

This site is intended for residents of the United Kingdom. Registered in England No 820771
Privacy Policy Terms of Use Copyright © 2004 [Subsidiary Name] Merck & CO., (USA)